Catalysis BioAdvisors

Strategic commercial and launch advisory for biopharma innovators

Helping emerging, mid-cap & MNC biopharma teams turn scientific innovation into sustainable, cross-functional commercial success across US, EU5 & Global markets

Advisory Focus: What We Do

Portfolio & Launch Strategy

  • Asset value and lifecycle planning (post-POC → LOE)

  • Portfolio integration and governance

  • Global-to-local commercial alignment (U.S., EU5, and JAPAC markets)

Commercial Strategy & iGBP

  • iGBP design and readiness

  • Cross-functional launch orchestration (medical, access, field)

  • Synchronized and accelerated approvals across priority markets

Digital & Omnichannel Innovation

  • Digital/CRM and analytics-enabled launch hubs

  • Multi-channel Field, Marketing, Medical, and Access resourcing and coordination

  • Patient and HCP engagement innovation

  • CoDx/DTx companion development programs

Enterprise-grade leadership — focused on your priorities

  • Principal-led delivery: You work directly with the advisor, not a junior team

  • Global + U.S. perspective: Country, regional, and HQ cross-functional leadership experience across Merck, Novartis, Amgen, and Biocon

  • Proven impact: 40+ global launches and $2B+ P&L leadership

  • Therapeutic breadth: Biologics/biosimilars, oncology, immunology, neurology, ophthalmology, CV/metabolism, and women’s health

  • Flexible engagement models: Advisory, project-based, or interim leadership

Interim & Executive Leadership

  • Acting ED/VP commercial leadership — from single engagements to longer-term advisory

  • Board/C-suite/investor-facing commercial narratives

  • Flexible project-based or advisory arrangements

Why Catalysis

About
Michael Border

I’m a global biopharmaceutical executive and advisor with over 25 years of experience leading cross-functional commercial strategy, integrated brand planning, and leading teams delivering integrated, market shaping launch execution across the U.S., EU5, and JAPAC markets

I’ve held senior leadership roles at Merck, Novartis, Amgen, and Biocon Biologics — including $2B+ P&L responsibility and more than 40 global product launches — and I founded Catalysis BioAdvisors LLC to help biopharma innovators accelerate growth, de-risk launches, and modernize go-to-market engagement models

Based in the U.S., supporting projects globally

Let’s Start the Conversation

Whether you’re planning a launch, shaping portfolio strategy, or expanding global capabilities, let’s explore how Catalysis BioAdvisors can accelerate your goals